NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?

Insider buying vs selling

Have Adial Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ADIL insiders and whales buy or sell their stock.

ADIL Shareholders

What type of owners hold Adial Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC178.89%2,554,442$4.47MInstitution
Cary J. Claiborne106.44%1,520,000$2.66MInsider
William B. Stilley Iii97.62%1,393,920$2.44MInsider
Bankole A. Johnson61.12%872,720$1.53MInsider
James W. Newman Jr.30.72%438,742$767.80kInsider
Joseph Truluck18.57%265,139$463.99kInsider
Citadel Advisors LLC15.38%219,621$384.34kInstitution
Vanguard Group Inc10.93%156,024$273.04kInstitution
Geode Capital Management LLC10.91%155,745$272.55kInstitution
Jane Street Group LLC8.53%121,841$213.22kInstitution

1 of 3

ADIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADIL43.37%56.63%
OGEN0.54%99.46%Net Selling
CLDI2.75%97.25%Net Buying
INM7.78%23.18%
CMND0.44%0.00%

Adial Pharmaceuticals Stock Ownership FAQ

Who owns Adial Pharmaceuticals?

Adial Pharmaceuticals (NASDAQ: ADIL) is owned by 247.64% institutional shareholders, 323.42% Adial Pharmaceuticals insiders, and 0.00% retail investors. Cary J. Claiborne is the largest individual Adial Pharmaceuticals shareholder, owning 1.52M shares representing 106.44% of the company. Cary J. Claiborne's Adial Pharmaceuticals shares are currently valued at $2.49M.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.